Lincoln National Stock (NYSE: LNCpD) cours de l'action, actualités, graphiques, recherche sur l'action, profil.

Lincoln National (NYSE:LNCpD) Stock Cotations, prévisions et résumé des actualités

Lincoln National

Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.

Lincoln National Corporation Depositary Shares Each Representing a 1/1,000th Interest in a Share of 9.000% Non-Cumulative Preferred Stock, Series D

Lincoln National Corp

The <a href="https://www.benzinga.com/topic/u-s-food-and-drug-administration">U.S. Food and Drug Administration</a> (FDA) on Thursday granted orphan drug designation to Sanofi SA&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) rilzabrutinib.
The treatment is an investigational, novel, advanced, oral, reversible Bruton's tyrosine kinase (BTK) inhibitor, for two rare diseases, warm autoimmune hemolytic anemia (wAIHA) and <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">IgG4-related disease (IgG4-RD)</a>.
The FDA grants orphan drug designation to investigational therapies that address rare medical diseases or conditions that affect fewer than 200,000 people in the US.
Rilzabrutinib is <a target="_blank" href="https://www.sanofi.com/en/media-room/press-releases/2025/2025-04-03-05-00-00-3054815" rel="noreferrer noopener">currently</a> under regulatory review in the US, the EU, and China for its potential use in immune thrombocytopenia (ITP).
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44440233/pharmaceutical-firms-say-uk-investment-is-unlikely-unless-payment-levy-is-adressed" rel="noreferrer noopener">Pharmaceutical Firms Say UK Investment Is &#8216;Unlikely&#8217; Unless Payment Levy Is Addressed</a>
The target action date for the FDA regulatory decision on ITP, which was granted fast-track designation, is Aug. 29.
Rilzabrutinib also received orphan drug designation for ITP in the US, EU, and Japan.
Results from a phase 2b study on wAIHA&nbsp;presented at ASH 2024 demonstrated that treatment with rilzabrutinib showed clinically meaningful outcomes on response rate and disease markers.
In IgG4-RD patients, results from a phase 2a study showed treatment with rilzabrutinib for 52 weeks led to reduction in disease flare, other disease markers, and glucocorticoid sparing.
The safety profile of rilzabrutinib in both studies was consistent with previous studies.
Last week, the FDA approved&nbsp;Sanofi&#8217;s Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients (aged 12 or older) with hemophilia A or B with or without&nbsp;<a target="_blank" href="https://www.benzinga.com/25/03/44560065/fda-approves-sanofis-hemophilia-drug" rel="noreferrer noopener">factor VIII or IX inhibitors</a>.
The&nbsp;<a target="_blank" href="https://www.sanofi.com/en/media-room/press-releases/2025/2025-03-28-20-07-38-3051637" rel="noreferrer noopener">approval</a>&nbsp;is based on data from the ATLAS phase 3 studies that demonstrated clinically meaningful bleed protection as measured by annualized bleeding rates.
Price Action: Sanofi&#8217;s stock is up 3.54% at $55.86 during the premarket session at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/44613863/biomarin-seeks-label-expansion-for-palynziq-after-positive-phase-3-results-in-adolescent-patients" target="_blank" rel="noreferrer noopener">BioMarin Seeks Label Expansion For Palynziq After Positive Phase 3 Results In Adolescent Patients</a></li>
</ul>
Image: Shutterstock

Biotech

Large Cap

News

Health Care

Movers

Trading Ideas

General

Why Is French Pharma Giant Sanofi Stock Trading Higher On Thursday?

WIIM

ASPI

CENX

FEAM

MATV

MEOH

MERC

PACK

TECK

VALE

Shares of companies within the broader materials sector are trading lower as markets react to President Trump's announcement of sweeping tariffs.

Macro Economic Events

Econ #s

Economics

Canada PM Carney Says: Call With Trump Helped Canada Avoid Reciprocal Tariffs

TD Securities analyst Craig Hutchison maintains Trilogy Metals (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TMQ#TSX">TMQ</a>) with a Hold and raises the price target from C$2 to C$2.25.

Price Target

Analyst Ratings

TSX:TMQ

TD Securities Maintains Hold on Trilogy Metals, Raises Price Target to C$2.25

<a href="https://investor.gm.com/news-releases/news-release-details/gm-reports-strong-q1-china-growth-evs-and-hybrids" title="https://investor.gm.com/news-releases/news-release-details/gm-reports-strong-q1-china-growth-evs-and-hybrids">https://investor.gm.com/news-releases/news-release-details/gm-reports-strong-q1-china-growth-evs-and-hybrids</a>

General Motors And Its Joint Ventures Announces It Delivered More Than 442,000 Units In China In Q1 2025

Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) just pulled back the curtain on its cloud ambitions at OCI Day, giving investors a close-up look at <a href="https://www.benzinga.com/topic/artificial-intelligence">its AI-powered</a> data center expansion.
While AI demand continues to surge, JPMorgan analyst Mark R. Murphy remains cautious, maintaining a Neutral stance on Oracle stock with a $135 price target, below its current trading level of $145.86.
<h1 class="wp-block-heading">AI Demand: Booming, But Is It Enough?</h1>
Oracle is doubling down on its AI infrastructure, expanding its customer-facing regions from 69 to 101 in the past year. But while the company insists demand is outpacing supply, Murphy notes that this messaging feels less urgent than before. 
Still, Oracle's investment in AI data centers suggests confidence in sustained demand, despite growing chatter about an "overbuild" or even an AI bubble.
Read Also: <a href="https://www.benzinga.com/news/25/04/44613084/amazon-makes-surprise-bid-for-tiktok-amid-us-ban-threat-report">Amazon&#8217;s Surprise Bid For TikTok As U.S. Ban Threat Looms</a>
<h1 class="wp-block-heading">Training Vs. Inferencing: Oracle Sees No Difference</h1>
One of the most debated topics in AI infrastructure is the difference between training (building models) and inferencing (running models). While Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) leans heavily on inferencing for steady revenue, Oracle argues that for major customers, both processes look the same. This implies a more persistent AI compute need than skeptics might believe, said Murphy.
<h1 class="wp-block-heading">Bubble Concerns? Oracle Hedging Its Bets</h1>
With Microsoft CEO Satya Nadella warning of an AI "overbuild" and Alibaba Group Holdings Ltd's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABAF#NYSE">BABAF</a>) chairman hinting at a potential bubble, Oracle's response was refreshingly pragmatic, Murphy noted.
Oracle Executive Vice President Clay Magouyrk dodged long-term predictions, instead emphasizing infrastructure flexibility — stating Oracle could repurpose its GPUs for general computing or storage if AI demand wanes. This adaptability could prove crucial if the AI hype cycle falters.
<h1 class="wp-block-heading">Oracle's Data Center Push: Big, But Not The Biggest</h1>
The event took place at Oracle's Novva facility in Utah, a massive operation but one dwarfed by neighboring Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Boeing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) data centers.
Oracle also showcased plans for an even larger facility in Abilene, Texas, suggesting its AI cloud ambitions are just getting started.
Murphy sees Oracle's AI-driven cloud expansion as a long-term play, but acknowledges near-term challenges — particularly hefty capital expenditures cutting into free cash flow.
While Oracle's growth trajectory is promising, it still faces hurdles in keeping up with hyperscaler giants. For now, the AI gold rush continues — but not without risks.
ORCL Price Action: Oracle stock is down 5.41% at $137.97 Thursday morning at publication.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/04/44601400/nvidia-rival-amd-completes-4-9b-acquisition-of-zt-systems-to-strengthen-ai-and-data-center-dominance">Nvidia Rival AMD Completes $4.9B Acquisition Of ZT Systems To Strengthen AI And Data Center Dominance</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Long Ideas

Tech

AMZN

BABA

ALIBABA GROUP HOLDING LTD by Alibaba Group Holding Limited

BABAF

MSFT

ORCL

Oracle's AI Bet: Overbuilt Or Future-Proof? Analyst Weighs In

Looking into the current session, Boston Scientific Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) shares are trading at $96.89, after a 3.16% drop. Over the past month, the stock fell by 1.95%, but over the past year, it actually spiked by 44.16%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1743696034_0.png" alt="Past Year Chart" />

<h3>Boston Scientific P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Boston Scientific has a lower P/E than the aggregate P/E of 81.19 of the Health Care Equipment &amp; Supplies industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743696034_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

Price Over Earnings Overview: Boston Scientific

American International Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>) short percent of float has risen 23.32% since its last report. The company recently reported that it has 16.23 million shares sold short, which is 3.12% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>American International Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743696028_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for American International Gr has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing American International Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, American International Gr's peer group average for short interest as a percentage of float is 1.98%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

What's Driving the Market Sentiment Around American International Gr?

National Bank Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBHC#NYSE">NBHC</a>) short percent of float has risen 10.79% since its last report. The company recently reported that it has 632 thousand shares sold short, which is 2.67% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.59 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>National Bank Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743696023_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for National Bank Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing National Bank Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, National Bank Holdings's peer group average for short interest as a percentage of float is 4.06%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

NBHC

What's Driving the Market Sentiment Around National Bank Holdings?

Caterpillar's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>) short percent of float has fallen 3.83% since its last report. The company recently reported that it has 9.71 million shares sold short, which is 2.01% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.62 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Caterpillar Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1743696018_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Caterpillar has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Caterpillar's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Caterpillar's peer group average for short interest as a percentage of float is 6.21%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Caterpillar's Recent Short Interest

Canada PM Carney Says: 25% Tariff On U.S.-Made Autos Could Raise Up To C$8B

ALLY

ATLC

Brighthouse Financial, Inc. - Common Stock

CRBG

DGICB

ENVA

FTFT

KINS

KSPI

LMND

OSCR

ROOT

SOFI

UPST

Shares of companies within the broader financials sector are trading lower as markets react to President Trump's announcement of sweeping tariffs.

ACHR

ACVA

AMPX

AMSC

AMTM

APWC

AVAV

AXON

AZEK

BYRN

EFOI

ELPW

ENVX

EOSE

FTAI

FWRD

HUBB

INOD

JOBY

LICN

LNZA

LUNR

MNTS

NIXX

NOTE

PCTY

REZI

RKLB

SIDU

SKIL

SNCY

SPCE

SRFM

STEM

SUNE

ULCC

VCIG

VICR

Shares of companies within the broader industrial sector are trading lower as markets react to President Trump's announcement of sweeping tariffs.

ARES

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BRDG

EMCG

FRHC

FUTU

HLNE

HOOD

IBKR

Janus Henderson Group plc Ordinary Shares

LPLA

LPRO

MKTW

NDAQ

NTRS

PIPR

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

SCHW

SNEX

SPGI

STEP

TROW

Shares of capital market companies are trading lower as markets react to President Trump's announcement of sweeping tariffs.

Canada PM Carney Says: Existing Retaliatory Tariffs To Remain In Place; We Would React Energetically To Any New U.S. Tariffs

Commerce Secretary Howard Lutnick believes the Trump Administration&#8217;s reciprocal tariffs will cause some short-term pain, but ultimately result in <a href="https://www.benzinga.com/top-stories/25/04/44627817/retaliation-odds-spike-after-trumps-heavy-tariffs-sending-country-etfs-tumbling">medium- and longer-term gain</a>.
What To Know: President Donald Trump announced sweeping reciprocal tariffs on numerous countries across the world Wednesday in what he called &#8220;Liberation Day&#8221; for America.
The tariff announcement sent markets into a tailspin with the SPDR S&amp;P 500 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) last down about 3.85%, per <a href="http://pro.benzinga.com">Benzinga Pro</a>. Economists fear the tariffs will spark a U.S. recession and global trade war.
Thursday on CNBC&#8217;s &#8220;Squawk Box,&#8221; Lutnick suggested that the stock market reaction will be short-lived as the tariff adjustments will spur other countries to reconsider trade policies.
&#8220;I think the long term or even the medium term, you&#8217;ve got to expect the United States of America markets are going to do extremely, extremely well,&#8221; the Commerce Secretary said.
See Also: <a href="https://www.benzinga.com/markets/25/04/44627820/trumps-reciprocal-tariffs-on-india-exempt-pharma-easing-mark-cubans-price-hike-concerns">Trump&#8217;s Reciprocal Tariffs On India Exempt Pharma, Easing Mark Cuban&#8217;s Price Hike Concerns</a>
Lutnick told CNBC he expects the tariffs to result in a &#8220;reordering of fair trade.&#8221; The move from the Trump Administration is not just in response to tariffs, it&#8217;s also in response to &#8220;non-tariff trade barriers.&#8221;
&#8220;I expect most countries to start to really examine their trade policy towards the United States of America and stop picking on us,&#8221; he said.
The Trump administration believes it has leverage to push other countries to reconsider trade policies with the U.S. Global investors fear potential retaliatory tactics that could significantly impact global economies.
&#8220;We&#8217;re talking to all the major countries of the world and we&#8217;ve been talking to them for more than a month,&#8221; Lutnick said.
&#8220;Will they treat us fairly? Can they treat us fairly? And the answer is, over time, that is going to be yes.&#8221;
The Commerce Secretary said America is going to become the producer of a lot more goods it consumes, interest rates will be much lower and the American economy will be much stronger over the longer term.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/25/04/44628368/trumps-tariffs-prompt-china-to-vow-countermeasures-experts-see-retaliation-likely">Trump&#8217;s Tariffs Prompt China To Vow &#8216;Countermeasures&#8217;: Experts See Retaliation Likely</a></li>
</ul>
Photo: <a href="https://www.shutterstock.com/g/JoshuaSukoff">Joshua Sukoff</a>/Shutterstock.

Government

Commerce Secretary Lutnick Says US Markets Will Perform 'Extremely Well' Long Term Despite Trump Tariff Selloff

Shares of Penguin Solutions Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>) tanked in early trading on Thursday, even after the company posted better-than-expected results for its <a href="https://www.benzinga.com/quote/PENG/earnings" target="_blank" rel="noreferrer noopener">second quarter on Wednesday</a>.
The company delivered "another strong quarter" and its progress in fiscal 2025 is tracking better than expected, according to Rosenblatt Securities.
The Penguin Solutions Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/59972d99803ad30001fc246d/kevin-cassidy">Analyst Kevin Cassidy</a> maintained a Buy rating and price target of $27.
The Penguin Solutions Thesis: The company posted revenue of $366 million, exceeding consensus of $344 million and representing the fifth quarter in a row of sequential growth,Cassidy said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
The outperformance was driven by "robust performance in Advanced Computing (+42% Y/Y), Integrated Memory (+26% Y/Y), and continued margin improvements in Optimized LED," he added.
Penguin Solutions reported new Advanced Computing customers and witnessed rising demand for its Memory Solutions, the analyst stated. "We see the addition of three new customers during the quarter as evidence of management&#8217;s strategy playing out and continuing demand for AI/HPC systems, software, and maintenance," he wrote.
The company ended the quarter with $647 million in cash and cash equivalents, up from $394 million in the prior quarter, Cassidy said.
Management raised their full-year revenue growth target from +15% to 17%.
PENG Price Action: Shares of Penguin Solutionshad declined by 10.19% to $16.21 at the time of publication on Thursday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43949618/cisco-and-nvidia-expand-ai-partnership-secure-us-government-authorization-for-cloud-security">US Stocks Likely To Open Lower Following Trump&#8217;s Tariffs: &#8216;Worse Than The Worst Case Scenario,&#8217; Says Analyst</a></li>
</ul>
Image: Shutterstock

Reiteration

Penguin Solutions, Inc. - Ordinary Shares

PENG

Penguin Solutions Delivers Strong Q2 Results, Analysts Say 2025 Is Tracking 'Above Expectations'

STLA

Canada PM Carney Says: Govt Stands In Solidarity With Stellantis Workers In Windsor, Ontario

Canada PM Carney Says: Govt To Provide Financial Help To Companies Affected By Canada Auto Tariffs

Canada PM Carney Says: Canada To Impose 25% Tariff On U.S.-Made Auto That Are Not USMCA Compliant; Canada Will Not Impose Tariffs on Auto Parts

Learn About Cryptocurrency

acf/sidebar-related-posts

Learn about this leading blockchain platform that supports decentralized applications and smart contracts.

What is Ethereum?

Earning interest on your Ethereum is a great way to grow your cryptocurrency holdings. Find out how to earn interest on your Ethereum in 4 easy steps.

How to Earn Interest on Ethereum

Discover the 10 best cryptocurrencies to invest in for January 2025. Stay ahead in the crypto market with our expert insights and analysis! Learn more now!

10 Best Cryptocurrencies to Invest In for April 2025

10 Best Cryptocurrencies to Invest in for January 2025

Discover the best altcoins to invest in for high potential returns. Our top altcoin picks include Ethereum, Solana, Ripple, Dogecoin, Toncoin.

Top 10 Best Altcoins • Benzinga Crypto

10 Best Altcoins in November 2024

Top Cryptocurrency News

acf/news-feed

Future Finance Newsletter

acf/page-sidebar-placement

Cryptocurrency /Money Sidebar

Ouverture	$26.45
Clôture	-
Volume / Moy.	20.18K / 29.80K
Fourchette Journalière	$26.37 - $26.60
Plage 52 Sem.	26.54 - 28.89
Capitalisation Boursière	-
Ratio P/E	-
Rendement des Dividendes	8.42%
Échange	NYSE
RSI	0
Intérêt à Découvert	-
Jours pour Couvrir	-

Ouverture	$26.45
Clôture	-
Volume / Moy.	20.18K / 29.80K
Fourchette Journalière	$26.37 - $26.60
Plage 52 Sem.	26.54 - 28.89
Capitalisation Boursière	-
Ratio P/E	-
Rendement des Dividendes	8.42%
Échange	NYSE
RSI	0
Intérêt à Découvert	-
Jours pour Couvrir	-

Comments

Lincoln National

Prévisions Lincoln National (LNCpD)

Lincoln National (NYSE:LNCpD) Stock Cotations, prévisions et résumé des actualités

Actualités récentes

Données financières

Comparer

FAQ

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Nom

Revenu Changement
Brut Changement
EBITDA Changement
EBIT Changement
Bénéfices Changement